Announcing our first Society Leadership & Development Programme Awardees (1)

Modern day environment promotes obesity (1)

EU approves type 2 diabetes drug for children (1)

04 Jul 2019

The Committee for Medicinal Products for Human Use of the European Medicines Agency has approved the GLP-1 agonist, liraglutide, for the treatment of children and adolescents with type 2 diabetes.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read